Major finding: [18F]FLT PET allows visualization of antigen-specific immune responses to DC therapy.
Impact: Responders can be discriminated from non-responders after anti-cancer vaccination.
Strategy: Proliferating immune cells selectively take up and retain [18F]FLT to allow in vivo imaging.
This content is only available via PDF.
©2011 American Association for Cancer Research.